CRESCENT BIOPHARMA, INC. Shares Outstanding (Cover Page)
CRESCENT BIOPHARMA, INC. (CBIO) had Shares Outstanding (Cover Page) of 37.14 million shares as of 2026-07-27, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-30
- 2026-07-27: Entity Common Stock, Shares Outstanding 37.14M shares.
- 2026-04-24: Entity Common Stock, Shares Outstanding 27.57M shares.
- 2026-02-23: Entity Common Stock, Shares Outstanding 27.56M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 13.89M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-27 | 37.14M shares 10-Q · filed 2026-07-30 |
| 2026-04-24 | 27.57M shares 10-Q/A · filed 2026-06-22 |
| 2026-02-23 | 27.56M shares 10-K · filed 2026-02-26 |
| 2025-11-03 | 13.89M shares 10-Q · filed 2025-11-06 |
| 2025-07-25 | 13.89M shares 10-Q · filed 2025-07-31 |
| 2025-05-12 | 64.53M shares 10-Q · filed 2025-05-14 |
| 2025-02-07 | 64.51M shares 10-K · filed 2025-02-13 |
| 2024-11-13 | 64.48M shares 10-Q · filed 2024-11-13 |
| 2024-08-07 | 64.48M shares 10-Q · filed 2024-08-08 |
| 2024-05-07 | 64.46M shares 10-Q · filed 2024-05-09 |
| 2024-03-25 | 64.45M shares 10-K · filed 2024-03-27 |
| 2023-11-01 | 64.39M shares 10-Q · filed 2023-11-03 |
| 2023-07-31 | 64.32M shares 10-Q · filed 2023-08-02 |
| 2023-05-01 | 64.25M shares 10-Q · filed 2023-05-03 |
| 2023-03-27 | 64.25M shares 10-K · filed 2023-03-29 |
| 2022-11-07 | 52.42M shares 10-Q · filed 2022-11-09 |
| 2022-08-01 | 52.42M shares 10-Q · filed 2022-08-03 |
| 2022-04-27 | 52.39M shares 10-Q · filed 2022-04-28 |
| 2022-02-28 | 52.31M shares 10-K · filed 2022-03-03 |
| 2021-10-29 | 51.74M shares 10-Q · filed 2021-11-02 |
| 2021-08-03 | 51.54M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 51.54M shares 10-Q · filed 2021-05-03 |
| 2021-02-26 | 51.49M shares 10-K · filed 2021-03-02 |
| 2020-11-04 | 47.83M shares 10-Q · filed 2020-11-06 |
| 2020-07-30 | 47.72M shares 10-Q · filed 2020-07-31 |
| 2020-04-29 | 43.58M shares 10-Q · filed 2020-05-01 |
| 2020-02-26 | 43.58M shares 10-K · filed 2020-02-28 |
| 2019-11-04 | 43.36M shares 10-Q · filed 2019-11-07 |
| 2019-07-30 | 43.19M shares 10-Q · filed 2019-08-01 |
| 2019-04-30 | 43.18M shares 10-Q · filed 2019-05-02 |
| 2019-02-28 | 43.17M shares 10-K · filed 2019-03-06 |
| 2018-10-31 | 43.14M shares 10-Q · filed 2018-11-02 |
| 2018-08-08 | 43.06M shares 10-Q · filed 2018-08-09 |
| 2018-05-01 | 42.50M shares 10-Q · filed 2018-05-03 |
| 2018-02-28 | 34.36M shares 10-K · filed 2018-03-06 |
| 2017-11-07 | 34.34M shares 10-Q · filed 2017-11-08 |
| 2017-08-02 | 32.72M shares 10-Q · filed 2017-08-03 |
| 2017-05-03 | 24.64M shares 10-Q · filed 2017-05-08 |
| 2017-02-27 | 23.33M shares 10-K · filed 2017-03-01 |
| 2016-11-03 | 23.07M shares 10-Q · filed 2016-11-04 |
| 2016-08-03 | 23.06M shares 10-Q · filed 2016-08-04 |
| 2016-05-02 | 19.35M shares 10-Q · filed 2016-05-04 |
| 2016-02-25 | 19.06M shares 10-K · filed 2016-02-29 |
| 2015-11-10 | 19.04M shares 10-Q · filed 2015-11-12 |
| 2015-08-04 | 19.02M shares 10-Q · filed 2015-08-06 |
| 2015-05-01 | 19.01M shares 10-Q · filed 2015-05-05 |
| 2015-03-10 | 18.99M shares 10-K · filed 2015-03-16 |
| 2014-10-29 | 18.89M shares 10-Q · filed 2014-10-31 |
| 2014-07-29 | 18.89M shares 10-Q · filed 2014-07-31 |
| 2014-05-08 | 18.79M shares 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |